Literature DB >> 14997173

RGSZ1 and GAIP regulate mu- but not delta-opioid receptors in mouse CNS: role in tachyphylaxis and acute tolerance.

Javier Garzón1, María Rodríguez-Muñoz, Almudena López-Fando, Antonio García-España, Pilar Sánchez-Blázquez.   

Abstract

In the CNS, the regulators of G-protein signaling (RGS) proteins belonging to the Rz subfamily, RGS19 (G(alpha) interacting protein (GAIP)) and RGS20 (Z1), control the activity of opioid agonists at mu but not at delta receptors. Rz proteins show high selectivity in deactivating G(alpha)z-GTP subunits. After reducing the expression of RGSZ1 with antisense oligodeoxynucleotides (ODN), the supraspinal antinociception produced by morphine, heroin, DAMGO ([D-Ala2, N-MePhe4,Gly-ol5]-enkephalin), and endomorphin-1 was notably increased. No change was observed in the effect of endomorphin-2. This agrees with the proposed existence of different mu receptors for the endomorphins. The activities of DPDPE ([D-Pen2,5]-enkephalin) and [D-Ala2] deltorphin II, agonists at delta receptors, were also unchanged. Knockdown of GAIP and of the GAIP interacting protein C-terminus (GIPC) led to changes in agonist effects at mu but not at delta receptors. The impairment of RGSZ1 extended the duration of morphine analgesia by at least 1 h beyond that observed in control animals. CTOP (Cys2, Tyr3, Orn5, Pen7-amide) antagonized morphine analgesia when given during the period in which the effect of morphine was enhanced by RGSZ1 knockdown. Thus, in naive mice, morphine tachyphylaxis originated in the presence of the opioid agonist and during the analgesia time course. The knockdown of RGSZ1 facilitated the development of tolerance to a single dose of morphine and accelerated tolerance to continuous delivery of the opioid. These results indicate that mu but not delta receptors are linked to Rz regulation. The mu receptor-mediated activation of Gz proteins is effective at recruiting the adaptive mechanisms leading to the development of opioid desensitization. Copyright 2004 Nature Publishing Group

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14997173     DOI: 10.1038/sj.npp.1300408

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  25 in total

1.  Variation in regulator of G-protein signaling 17 gene (RGS17) is associated with multiple substance dependence diagnoses.

Authors:  Huiping Zhang; Fan Wang; Henry R Kranzler; Raymond F Anton; Joel Gelernter
Journal:  Behav Brain Funct       Date:  2012-05-16       Impact factor: 3.759

Review 2.  Look before leaping: combined opioids may not be the rave.

Authors:  Mellar P Davis; Susan B LeGrand; Ruth Lagman
Journal:  Support Care Cancer       Date:  2005-07-06       Impact factor: 3.603

3.  Ultrastructural relationship between the AMPA-GluR2 receptor subunit and the mu-opioid receptor in the mouse central nucleus of the amygdala.

Authors:  Marc A Beckerman; Michael J Glass
Journal:  Exp Neurol       Date:  2010-10-21       Impact factor: 5.330

4.  A physiologically required G protein-coupled receptor (GPCR)-regulator of G protein signaling (RGS) interaction that compartmentalizes RGS activity.

Authors:  Wayne Croft; Claire Hill; Eilish McCann; Michael Bond; Manuel Esparza-Franco; Jeannette Bennett; David Rand; John Davey; Graham Ladds
Journal:  J Biol Chem       Date:  2013-07-30       Impact factor: 5.157

Review 5.  How regulators of G protein signaling achieve selective regulation.

Authors:  Guo-Xi Xie; Pamela Pierce Palmer
Journal:  J Mol Biol       Date:  2006-11-15       Impact factor: 5.469

Review 6.  Regulator of G Protein Signaling 17 as a Negative Modulator of GPCR Signaling in Multiple Human Cancers.

Authors:  Michael P Hayes; David L Roman
Journal:  AAPS J       Date:  2016-02-29       Impact factor: 4.009

7.  The Benefits of Genetic Addiction Risk Score (GARS) Testing in Substance Use Disorder (SUD).

Authors:  Kenneth Blum; Edward J Modestino; Marjorie Gondre-Lewis; Edwin J Chapman; Jennifer Neary; David Siwicki; David Baron; Mary Hauser; David E Smith; Alphonse Kenison Roy; Panayotis K Thanos; Bruce Steinberg; Thomas McLaughlin; Lyle Fried; Debmalya Barh; Georgia A Dunston; Rajendra D Badgaiyan
Journal:  Int J Genom Data Min       Date:  2018-01-15

8.  GPER1 stimulation alters posttranslational modification of RGSz1 and induces desensitization of 5-HT1A receptor signaling in the rat hypothalamus.

Authors:  Carrie E McAllister; Zhen Mi; Minae Mure; Qian Li; Nancy A Muma
Journal:  Neuroendocrinology       Date:  2014-11-07       Impact factor: 4.914

9.  GIPC recruits GAIP (RGS19) to attenuate dopamine D2 receptor signaling.

Authors:  Freddy Jeanneteau; Olivier Guillin; Jorge Diaz; Nathalie Griffon; Pierre Sokoloff
Journal:  Mol Biol Cell       Date:  2004-09-08       Impact factor: 4.138

10.  Gz mediates the long-lasting desensitization of brain CB1 receptors and is essential for cross-tolerance with morphine.

Authors:  Javier Garzón; Elena de la Torre-Madrid; María Rodríguez-Muñoz; Ana Vicente-Sánchez; Pilar Sánchez-Blázquez
Journal:  Mol Pain       Date:  2009-03-10       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.